Literature DB >> 9641514

Polyarthritis, rash and lymphadenopathy: case reports of two patients with angioimmunoblastic lymphadenopathy presenting to a rheumatology clinic.

M A Layton1, C Musgrove, P T Dawes.   

Abstract

Two patients presented with a symmetrical inflammatory polyarthropathy. Both patients fulfilled the diagnostic criteria for angioimmunoblastic lymphadenopathy. We present the two case histories and review the current literature. Although an uncommon disease, the diagnosis of angioimmunoblastic lymphadenopathy should be considered in a patient presenting with polyarthritis and skin rash.

Entities:  

Mesh:

Year:  1998        PMID: 9641514     DOI: 10.1007/bf01452263

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

2.  Systemic lupus erythematosus and angioimmunoblastic lymphadenopathy: case report and review of the literature.

Authors:  E D Rosenstein; R Wieczorek; B G Raphael; B Agus
Journal:  Semin Arthritis Rheum       Date:  1986-11       Impact factor: 5.532

3.  Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A.

Authors:  T Murayama; S Imoto; T Takahashi; M Ito; S Matozaki; T Nakagawa
Journal:  Cancer       Date:  1992-05-15       Impact factor: 6.860

Review 4.  Peripheral T-cell lymphomas.

Authors:  H Stein; D Dienemann; F Dallenbach; M Kruschwitz
Journal:  Ann Oncol       Date:  1991-02       Impact factor: 32.976

5.  Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group.

Authors:  W Siegert; C Nerl; A Agthe; M Engelhard; G Brittinger; M Tiemann; K Lennert; D Huhn
Journal:  Ann Oncol       Date:  1995-09       Impact factor: 32.976

6.  Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group.

Authors:  W Siegert; A Agthe; H Griesser; R Schwerdtfeger; G Brittinger; M Engelhard; R Kuse; M Tiemann; K Lennert; D Huhn
Journal:  Ann Intern Med       Date:  1992-09-01       Impact factor: 25.391

Review 7.  [Angioimmunoblastic lymphadenopathy with dysproteinemia: personal experience with 3 cases and review of the literature].

Authors:  M Di Natale; P Biagioni; R Fiusti; M Grassi; M Santini; F Corradi
Journal:  Minerva Med       Date:  1993-12       Impact factor: 4.806

8.  Clinicopathologic and therapeutic aspects of angioimmunoblastic lymphadenopathy-related lesions.

Authors:  A Ohsaka; K Saito; T Sakai; S Mori; Y Kobayashi; Y Amemiya; S Sakamoto; Y Miura
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

9.  Synovitis in angioimmunoblastic lymphadenopathy with dysproteinemia simulating rheumatoid arthritis.

Authors:  D T Boumpas; M S Wheby; E S Jaffe; A D Steinberg; J H Klippel; J E Balow
Journal:  Arthritis Rheum       Date:  1990-04

10.  Angioimmunoblastic lymphadenopathy with disproteinemia arising in a patient with rheumatoid arthritis.

Authors:  K Ozoran; M Turgay; G Kinikli; M Duman; O Tolunay; G Tokgöz
Journal:  Scand J Rheumatol       Date:  1995       Impact factor: 3.641

View more
  1 in total

1.  Angioimmunoblastic T-Cell Lymphoma with Polyarthritis Resembling Rheumatoid Arthritis.

Authors:  Ralph Yachoui; Nouman Farooq; Jonathan V Amos; Gene R Shaw
Journal:  Clin Med Res       Date:  2016-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.